Literature DB >> 8113475

Stevens-Johnson syndrome after terbinafine therapy.

B Rzany, M Mockenhaupt, W Gehring, E Schöpf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8113475     DOI： 10.1016/s0190-9622(08)81961-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  7 in total

1.  [Facial pigmentation following therapy with terbinafine].

Authors:  K Breuer; B Völker; R Gutzmer; A Kapp; T Werfel
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

Review 2.  Terbinafine. An update of its use in superficial mycoses.

Authors:  K J McClellan; L R Wiseman; A Markham
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

3.  Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts.

Authors:  A Mallat; E S Zafrani; J M Metreau; D Dhumeaux
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

Review 4.  Management of onychomycoses.

Authors:  M Niewerth; H C Korting
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

5.  Update on terbinafine with a focus on dermatophytoses.

Authors:  Jason G Newland; Susan M Abdel-Rahman
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-04-21

Review 6.  Generalized pustular psoriasis and hepatic dysfunction associated with oral terbinafine therapy.

Authors:  Byung-Soo Kim; Ho-Sun Jang; Seung-Wook Jwa; Bong-Seok Jang; Moon-Bum Kim; Chang-Keun Oh; Yoo-Wook Kwon; Kyung-Sool Kwon
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

Review 7.  Rare drug allergies: Review on prevalence and test procedures.

Authors:  R Treudler; J C Simon
Journal:  Allergol Select       Date:  2017-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.